LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_203407.3:c.741A>T
EZHIP
· NP_981952.1:p.(Pro247=)
· NM_203407.3
GRCh37: chrX:51150609 A>T
·
GRCh38: chrX:51407757 A>T
Gene:
EZHIP
Transcript:
NM_203407.3
Final call
Likely Benign
PM2 supporting
BP4 supporting benign
BP7 supporting benign
Variant details
Gene
EZHIP
Transcript
NM_203407.3
Protein
NP_981952.1:p.(Pro247=)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
NM_203407.3:c.741A>T is a synonymous variant (Pro247=) in EZHIP, encoding EZH Inhibitory Protein. No CSPEC or VCEP framework exists for this gene; generic ACMG/AMP 2015 criteria are applied.
2
This variant is absent from all population databases including gnomAD v2.1, v4.1, and gnomAD-Canada (PM2 at supporting strength, discounted for synonymous variant with no predicted functional impact).
3
Multiple lines of computational evidence suggest no impact on the gene product: SpliceAI predicts no splice alteration (max delta 0.02), and the variant is synonymous, preserving the amino acid sequence (BP4, supporting benign).
4
The variant satisfies BP7 criteria as a synonymous variant with no predicted splice impact per SpliceAI (supporting benign).
5
Overall, one supporting pathogenic criterion (PM2) and two supporting benign criteria (BP4, BP7) are met. The evidence is balanced, resulting in a classification of Variant of Uncertain Significance (VUS).
Final determination:
Generic ACMG/AMP 2015 fallback rules support a Likely Benign classification because either one strong benign criterion plus one supporting benign criterion, or at least two supporting benign criteria, are present.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | NM_203407.3:c.741A>T is a synonymous variant (NP_981952.1:p.(Pro247=)) with no predicted null effect on protein function. It does not fall into any PVS1 null-variant bucket (nonsense, frameshift, or canonical ±1,2 splice consensus variants) per ClinGen SVI PVS1 recommendations (PMC6185798). |
pvs1_generic_framework
|
| PS1 | N/A | This is a synonymous variant with no amino acid change. PS1 requires a known pathogenic missense change at the same codon, which is inapplicable to synonymous variants. |
|
| PS2 | Not met | No de novo observations have been reported for NM_203407.3:c.741A>T in any available data source. |
|
| PS3 | Not met | No functional studies have been identified for NM_203407.3:c.741A>T. No variant-specific or systematic-range functional data exists for this synonymous variant. |
|
| PS4 | Not met | No case-control or statistical evidence supports enrichment of this variant in affected individuals. The variant is absent from ClinVar and has not been reported in any disease cohort. |
clinvar
|
| PS5 | N/A | This variant is absent from ClinVar; no classification by an expert panel or multiple submitters exists to satisfy PS5. |
clinvar
|
| PM1 | Not met | NM_203407.3:c.741A>T (Pro247=) is not located within a statistically significant mutational hotspot per cancerhotspots.org, and no critical functional domain has been characterized at this specific residue position for EZHIP. |
|
| PM2 | Met | NM_203407.3:c.741A>T is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, consistent with a rare variant. However, as a synonymous variant with no predicted splice or functional impact, the absence from population databases provides limited evidence of pathogenicity; applied at supporting strength. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM5 | N/A | No missense comparator variant exists at the same residue. NM_203407.3:c.741A>T is synonymous (Pro247=) and does not produce an amino acid change; PM5 semantics require alternative missense changes at the same position, which are not applicable. |
|
| PM6 | Not met | No de novo observation has been reported for NM_203407.3:c.741A>T. |
|
| PP1 | Not met | No segregation data is available for NM_203407.3:c.741A>T. |
|
| PP2 | N/A | PP2 applies specifically to missense variants in genes with a low rate of benign missense variation. NM_203407.3:c.741A>T is a synonymous variant and does not qualify. |
|
| PP3 | Not met | Multiple in silico tools do not predict a deleterious effect. SpliceAI predicts no significant splice impact (max delta score = 0.02, well below the 0.2 threshold). REVEL and BayesDel scores are not available for this variant. Available computational evidence does not support a pathogenic role. |
spliceai
|
| PP4 | Not met | No phenotype specificity data is available for NM_203407.3:c.741A>T. The variant has not been reported in any clinical cohort with a defined phenotype. |
|
| PP5 | N/A | NM_203407.3:c.741A>T is absent from ClinVar; no reputable source has classified this variant as pathogenic. No 3-star expert panel classification exists. |
clinvar
|
| BA1 | Not met | NM_203407.3:c.741A>T is absent from gnomAD v2.1 and v4.1 (allele frequency = 0). The BA1 threshold of >1% in population databases is not met. |
gnomad_v2
gnomad_v4
|
| BS1 | Not met | NM_203407.3:c.741A>T is absent from gnomAD (AF = 0). The BS1 threshold of >0.3% allele frequency in population databases is not met. |
gnomad_v2
gnomad_v4
|
| BS2 | Not met | No homozygous adult observations or unaffected carrier data have been reported for NM_203407.3:c.741A>T. |
|
| BS3 | Not met | No functional studies have been performed demonstrating that NM_203407.3:c.741A>T has no deleterious effect. No well-established in vitro or in vivo assays exist for this variant. |
|
| BS4 | Not met | No segregation data is available to evaluate lack of cosegregation with disease for NM_203407.3:c.741A>T. |
|
| BP1 | N/A | BP1 applies specifically to missense variants in genes where primarily truncating variants cause disease. NM_203407.3:c.741A>T is a synonymous variant and does not meet the missense requirement. |
|
| BP2 | Not met | No observation of NM_203407.3:c.741A>T in trans with a pathogenic variant has been reported. |
|
| BP3 | N/A | Skipped per case instructions — trivially not applicable (in-frame indels in repetitive regions). |
|
| BP4 | Met | Multiple lines of computational evidence suggest NM_203407.3:c.741A>T has no impact on the gene product. SpliceAI predicts no significant splice impact (max delta score = 0.02, well below the standard 0.2 threshold). The variant is synonymous, predicted to preserve the amino acid sequence (Pro247=). No in silico tool predicts a deleterious effect. |
spliceai
|
| BP5 | Not met | No case has been identified in which NM_203407.3:c.741A>T is found alongside an alternate molecular basis for disease. |
|
| BP6 | N/A | NM_203407.3:c.741A>T is absent from ClinVar; no reputable source has classified this variant as benign. No 3-star expert panel classification exists. |
clinvar
|
| BP7 | Met | NM_203407.3:c.741A>T is a synonymous variant (Pro247=) for which SpliceAI predicts no impact on the splice consensus sequence nor creation of a new splice site (max delta score = 0.02, acceptor gain DS_AG = 0.02, all other deltas = 0.0). Conservation data is unavailable but does not contradict BP7 application. |
spliceai
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.